Development of a nanoliposomal formulation of erlotinib for lung cancer and in vitro/in vivo antitumoral evaluation
Xiao Zhou, Hui Tao, Kai-Hu Shi Department of Cardiothoracic Surgery, The Second Hospital of Anhui Medical University, Hefei, People’s Republic of China Abstract: The aim of this study was to develop PEGylation liposomes formulations of erlotinib and evaluate their characteristics, stability,...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2017-12-01
|
| シリーズ: | Drug Design, Development and Therapy |
| 主題: | |
| オンライン･アクセス: | https://www.dovepress.com/development-of-a-nanoliposomal-formulation-of-erlotinib-for-lung-cance-peer-reviewed-article-DDDT |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|